GO:0051119 sugar transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051119 (sugar transmembrane transporter activity) is a molecular function that enables the transfer of a sugar across a membrane.
• Sugar transporters are divided into active and passive systems, with the latter including facilitated diffusion carriers and channels.
• The SLC2 (GLUT) family mediates facilitative hexose transport, while SLC5 (SGLT) proteins perform active sodium-coupled sugar transport.
• The SLC37 family comprises sugar-phosphate/phosphate exchangers that transport glucose-6-phosphate into the endoplasmic reticulum.
• GLUT8 (SLC2A8) is an intracellular hexose transporter with a unique endosomal localization and a dileucine motif.
• Dysregulation of sugar transport is linked to insulin secretion defects, metabolic disorders, and cancer.
Description
Sugar transmembrane transporter activity (GO:0051119) is a molecular function that enables the transfer of a sugar from one side of a membrane to the other. This activity is fundamental to cellular metabolism, as sugars serve as primary energy sources and biosynthetic precursors. The term encompasses both active and passive transport mechanisms, including facilitated diffusion and secondary active transport. In eukaryotes, sugar transporters are critical for glucose uptake in tissues such as muscle and adipose, and for glucose reabsorption in the kidney. The physiological importance of these transporters is underscored by their roles in insulin secretion from pancreatic beta cells, where glucose uptake and metabolism are tightly coupled to hormone release. Moreover, sugar transporters are implicated in a growing number of human diseases, including diabetes, cancer, and developmental disorders. Understanding the molecular mechanisms, regulation, and disease associations of sugar transmembrane transporter activity is therefore essential for both basic research and therapeutic development.
sugar transmembrane transporter activity At A Glance
| GO ID | GO:0051119 |
|---|---|
| GO term | sugar transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | sugar/polyol channel activity |
| Major function | Transfer of a sugar from one side of a membrane to the other |
| Definition source | QuickGO |
| Related transporters | GLUT (SLC2), SGLT (SLC5), SLC37, and others |
| Disease relevance | Diabetes, cancer, metabolic disorders, and developmental syndromes |
What Is GO:0051119?
The Gene Ontology term GO:0051119, sugar transmembrane transporter activity, is defined as enabling the transfer of a sugar from one side of a membrane to the other. A sugar is any member of a class of sweet, water-soluble, crystallizable carbohydrates, which are the monosaccharides and smaller oligosaccharides. This activity is a molecular function that can be carried out by various proteins, including channels, carriers, and pumps, and is distinct from sugar binding or sugar metabolism. The synonym sugar/polyol channel activity reflects a subset of transporters that form channels for sugar or polyol movement.
Why Is sugar transmembrane transporter activity Important in Cell Biology?
Sugar transmembrane transporter activity is essential for maintaining cellular energy homeostasis and providing substrates for metabolic pathways. In pancreatic beta cells, glucose uptake via GLUT2 and subsequent metabolism are required for glucose-stimulated insulin secretion, a process that is impaired in diabetes. In the kidney, sodium-coupled glucose transporters (SGLTs) reabsorb glucose from the filtrate, and their inhibition is a therapeutic strategy for diabetes. Furthermore, sugar transporters are often upregulated in cancer cells to support the increased demand for glucose and other sugars, a phenomenon known as the Warburg effect. Mutations in sugar transporter genes can cause rare diseases, such as GLUT1 deficiency syndrome, highlighting their critical roles in human health. Thus, studying sugar transmembrane transporter activity is vital for understanding normal physiology and disease pathogenesis.
• Enables glucose uptake in tissues such as muscle, adipose, and brain.
• Critical for glucose-stimulated insulin secretion in pancreatic beta cells.
• Mediates renal glucose reabsorption via SGLTs, a target for diabetes therapy.
• Supports increased metabolic demands of cancer cells.
• Mutations in sugar transporters cause diseases like GLUT1 deficiency syndrome.
• Facilitates transport of sugar phosphates into the endoplasmic reticulum for glycoprotein synthesis.
• Regulates intracellular hexose levels and signaling.
• Involved in drug/metabolite transport superfamily, indicating broad substrate range.
• Potential target for anti-diabetic and anti-cancer drugs.
• Essential for normal development and function of multiple organs.
Mechanism, Genes and Research Methods
What Happens During sugar transmembrane transporter activity?
In simple terms: Sugar transporters move sugars across cell membranes, either with or without energy.
Sugar transmembrane transporter activity encompasses several transport mechanisms. Active sugar transport in eukaryotes is often driven by ion gradients, such as the sodium gradient, as seen in SGLT proteins. These transporters couple the movement of sodium down its concentration gradient to the uphill transport of sugar into the cell. In contrast, facilitative diffusion transporters, such as GLUTs, allow sugars to move down their concentration gradient without direct energy input. Some transporters, like the SLC37 family, act as sugar-phosphate/phosphate exchangers, transporting glucose-6-phosphate into the endoplasmic reticulum in exchange for phosphate. The overall process involves substrate recognition, conformational changes, and release of the sugar on the other side of the membrane.
Structure and Composition of sugar transmembrane transporter activity
In simple terms: Sugar transporters are membrane proteins with specific structural folds that create a pathway for sugars.
Sugar transporters typically contain multiple transmembrane helices that form a substrate translocation pathway. The GLUT family members (SLC2) share a common structure with 12 transmembrane segments and intracellular N- and C-termini. SGLT proteins (SLC5) also have 14 transmembrane segments and function as sodium-coupled symporters. The SLC37 family members are predicted to have 10 transmembrane helices and function as dimers or higher-order oligomers. Some sugar transporters, like GLUT8, contain sorting motifs such as a dileucine motif that directs them to intracellular compartments. The structural diversity reflects adaptations to different substrates, transport modes, and regulatory mechanisms.
Molecular Mechanism of sugar transmembrane transporter activity
In simple terms: The transporter binds a sugar and undergoes shape changes to move it across the membrane.
At the molecular level, sugar transporters operate via alternating access mechanisms. For facilitative transporters, the protein alternates between outward-facing and inward-facing conformations, allowing the sugar to enter from one side and exit on the other. For sodium-coupled transporters, the binding of sodium and sugar is ordered, with sodium binding first and sugar binding second, followed by a conformational change that releases both substrates into the cytoplasm. The SLC37 exchangers catalyze the exchange of glucose-6-phosphate with phosphate, a process that may involve a ping-pong mechanism. Regulation can occur through expression levels, post-translational modifications, and interaction with accessory proteins. For example, GLUT8 is regulated by its intracellular localization and potentially by sugar availability.
Regulation of sugar transmembrane transporter activity
In simple terms: Cells control sugar transport by adjusting the number and activity of transporters.
Sugar transport activity is regulated at multiple levels. Hormones such as insulin stimulate glucose uptake in muscle and fat by promoting translocation of GLUT4 to the plasma membrane. In pancreatic beta cells, glucose metabolism generates signals that regulate insulin secretion, indirectly affecting sugar transporter expression. The SLC37 family members are regulated by their expression levels and possibly by substrate availability. GLUT8 is regulated by its intracellular retention and can be mobilized to the cell surface in response to specific stimuli. Additionally, sugar transporters can be regulated by phosphorylation, ubiquitination, and interaction with regulatory proteins. Dysregulation of these regulatory mechanisms contributes to diseases such as diabetes and cancer.
Key Genes Involved in GO:0051119 sugar transmembrane transporter activity
The following genes encode proteins that exhibit sugar transmembrane transporter activity, as documented in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Facilitative glucose transporter | Glucose uptake in brain and erythrocytes; mutations cause GLUT1 deficiency syndrome |
| SLC2A2 (GLUT2) | Facilitative glucose transporter | Glucose sensing in pancreatic beta cells and liver |
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter | Glucose uptake in muscle and adipose tissue |
| SLC2A8 (GLUT8) | Intracellular hexose transporter | Endosomal transport; role in metabolism and reproduction |
| SLC5A1 (SGLT1) | Sodium-coupled glucose transporter | Intestinal glucose absorption; mutations cause glucose-galactose malabsorption |
| SLC5A2 (SGLT2) | Sodium-coupled glucose transporter | Renal glucose reabsorption; target for diabetes drugs |
| SLC37A1 | Sugar-phosphate/phosphate exchanger | Glucose-6-phosphate transport in endoplasmic reticulum |
| SLC37A2 | Sugar-phosphate/phosphate exchanger | Similar to SLC37A1; involved in glycolytic pathway |
| SLC37A3 | Sugar-phosphate/phosphate exchanger | Expressed in various tissues; role in sugar phosphate transport |
| SLC37A4 | Sugar-phosphate/phosphate exchanger | Glucose-6-phosphate transport; mutations cause glycogen storage disease type Ib |
| SLC35A1 | CMP-sialic acid transporter | Golgi sialic acid transport; not a sugar transporter per se but related |
| SLC33A1 | Acetyl-CoA transporter | Golgi sialic acid O-acetylation; interplay with CASD1 |
| UAT (SLC22A12) | Urate transporter/channel | Sugar-regulated urate transport; galectin 9 binding |
| GLUT3 (SLC2A3) | Facilitative glucose transporter | Neuronal glucose uptake |
| GLUT5 (SLC2A5) | Fructose transporter | Fructose uptake in intestine and sperm |
| SGLT3 (SLC5A4) | Glucose sensor | Not a transporter but a glucose sensor in cholinergic neurons |
| SLC50A1 | Sugar transporter | Putative sugar transporter in mammals; less characterized |
How Is sugar transmembrane transporter activity Regulated?
Sugar transmembrane transporter activity is regulated by hormonal signals, substrate availability, and cellular stress. Insulin promotes the translocation of GLUT4 to the plasma membrane in muscle and adipose tissue, thereby increasing glucose uptake. In pancreatic beta cells, glucose metabolism leads to ATP production, which closes KATP channels, depolarizes the membrane, and triggers insulin secretion; this process is dependent on glucose transport and metabolism. The SLC37 family members are regulated by their expression levels and possibly by the availability of their substrates, glucose-6-phosphate and phosphate. GLUT8 is regulated by its intracellular localization, which is mediated by a dileucine motif, and can be mobilized to the cell surface in response to specific stimuli. Additionally, sugar transporters can be regulated by post-translational modifications such as phosphorylation and ubiquitination, although the specific mechanisms vary among family members.
sugar transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 (GLUT1) | GLUT1 deficiency syndrome | Knockout or point mutation in neurons or brain endothelial cells |
| SLC2A2 (GLUT2) | Fanconi-Bickel syndrome | Liver-specific knockout or knock-in of patient mutations |
| SLC5A2 (SGLT2) | Diabetes mellitus | Kidney-specific knockout or overexpression |
| SLC37A4 | Glycogen storage disease type Ib | Liver-specific knockout or point mutation |
| SLC2A8 (GLUT8) | Metabolic and reproductive disorders | Global or tissue-specific knockout |
Diabetes and Metabolic Disorders
Impaired sugar transport contributes to the pathogenesis of diabetes. In pancreatic beta cells, reduced glucose uptake and metabolism can lead to decreased insulin secretion, a hallmark of type 2 diabetes. Mutations in SLC2A2 (GLUT2) cause Fanconi-Bickel syndrome, characterized by glycogen accumulation and glucose intolerance. SGLT2 inhibitors are used to treat type 2 diabetes by blocking renal glucose reabsorption, leading to increased urinary glucose excretion. Thus, sugar transporters are key therapeutic targets in diabetes.
Cancer
Cancer cells often exhibit increased glucose uptake to support rapid proliferation, a phenomenon known as the Warburg effect. Overexpression of GLUT1 and GLUT3 is common in many cancers and is associated with poor prognosis. Targeting sugar transporters is being explored as an anti-cancer strategy. For example, GLUT8 is expressed in some cancers and may contribute to their metabolic adaptation.
Glycogen Storage Diseases
Mutations in SLC37A4, a sugar-phosphate/phosphate exchanger, cause glycogen storage disease type Ib, characterized by hypoglycemia, hepatomegaly, and neutropenia. This highlights the importance of sugar phosphate transport into the endoplasmic reticulum for normal glucose homeostasis.
Neurological Disorders
GLUT1 deficiency syndrome is caused by mutations in SLC2A1 and leads to impaired glucose transport across the blood-brain barrier, resulting in seizures, developmental delay, and movement disorders. This demonstrates the critical role of sugar transporters in brain function.
From sugar transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of GLUT1 loss on brain glucose uptake? | Conditional knockout in brain endothelial cells |
| How do SGLT2 mutations affect renal glucose reabsorption? | Knock-in of patient mutations in kidney cells |
| Does GLUT4 overexpression improve insulin sensitivity? | Transgenic overexpression in muscle |
| What is the role of SLC37A4 in glycogen storage? | Liver-specific knockout |
| How does GLUT8 localization affect hexose transport? | Tagged knock-in with fluorescent protein |
| Can sugar transporter inhibitors be tested in vivo? | Xenograft models with transporter overexpression |
How to Study the sugar transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled sugar uptake | Transport rate and kinetics | Characterization of transporter substrate specificity |
| Patch-clamp electrophysiology | Transport currents | Study of electrogenic transporters like SGLTs |
| Fluorescence microscopy | Transporter localization and trafficking | Live-cell imaging of tagged transporters |
| CRISPR knockout | Loss-of-function effects | Identifying essential transporters |
| RNA-seq | Expression levels of transporter genes | Tissue-specific expression profiling |
| Proteomics | Protein abundance and interactions | Identifying transporter complexes |
| Metabolomics | Intracellular sugar levels | Assessing metabolic impact of transport |
| Structural biology (cryo-EM) | 3D structure of transporters | Understanding transport mechanism |
Transport Assays
Radiolabeled sugar uptake assays are used to measure the activity of sugar transporters in cells or membrane vesicles. For example, 14C- or 3H-labeled glucose or fructose can be used to monitor transport kinetics. These assays can be performed in the presence or absence of inhibitors to determine specificity and mechanism.
Electrophysiology
For electrogenic transporters such as SGLTs, patch-clamp or two-electrode voltage clamp can measure transport currents. This technique provides real-time measurements of transporter activity and substrate specificity.
Fluorescence Microscopy
Fluorescently tagged sugars or transporter-specific antibodies can be used to visualize transporter localization and trafficking in live cells. For example, GFP-tagged GLUT8 can be used to study its intracellular dynamics.
Genetic Knockout and Knockdown
CRISPR/Cas9-mediated knockout or RNA interference can be used to deplete specific sugar transporters and assess their contribution to sugar uptake and cellular metabolism. This approach is valuable for identifying the roles of individual transporters in complex systems.
How CRISPR Can Be Used to Study GO:0051119 sugar transmembrane transporter activity
Knockout
CRISPR/Cas9 knockout of sugar transporter genes is used to study their physiological roles. For example, knockout of SLC2A1 in cells leads to reduced glucose uptake and altered metabolism. Knockout models can be generated in cell lines or animals to assess the impact on development and disease.
Point Mutation
Point mutations identified in patients can be introduced into the endogenous gene using CRISPR/Cas9 and homology-directed repair. This allows researchers to study the functional consequences of specific mutations, such as those in SLC2A1 that cause GLUT1 deficiency syndrome.
Knock-in
Knock-in of reporter genes or tags, such as GFP, into sugar transporter loci enables real-time visualization of transporter expression and localization. For example, a GFP knock-in at the SLC2A8 locus can be used to track GLUT8 trafficking.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to increase the expression of sugar transporters. This is useful for studying the effects of enhanced sugar uptake on cellular metabolism and disease models, such as cancer.
How EDITGENE Supports sugar transmembrane transporter activity Research
Researchers studying sugar transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in sugar transport, metabolic regulation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for sugar transmembrane transporter activity research.
Frequently Asked Questions About sugar transmembrane transporter activity
What is sugar transmembrane transporter activity?
Sugar transmembrane transporter activity (GO:0051119) is a molecular function that enables the transfer of a sugar from one side of a membrane to the other, as defined by the Gene Ontology.
What genes are involved in sugar transmembrane transporter activity?
Genes encoding sugar transporters include SLC2A1 (GLUT1), SLC2A2 (GLUT2), SLC2A4 (GLUT4), SLC5A1 (SGLT1), SLC5A2 (SGLT2), and SLC37A4, among others.
How do sugar transporters work?
Sugar transporters work by alternating between outward-facing and inward-facing conformations to move sugars across the membrane, either via facilitated diffusion or active transport coupled to ion gradients.
What diseases are associated with sugar transporter mutations?
Mutations in sugar transporters can cause GLUT1 deficiency syndrome, Fanconi-Bickel syndrome, glycogen storage disease type Ib, and contribute to diabetes and cancer.
What is the role of GLUT8 in sugar transport?
GLUT8 (SLC2A8) is an intracellular hexose transporter that localizes to endosomes and is regulated by a dileucine motif; it plays roles in metabolism and reproduction.
How can I study sugar transmembrane transporter activity in the lab?
Common methods include radiolabeled sugar uptake assays, electrophysiology, fluorescence microscopy, and CRISPR knockout models.
What is the difference between GLUT and SGLT transporters?
GLUT transporters facilitate diffusion of sugars down their concentration gradient, while SGLT transporters use the sodium gradient to actively transport sugars against their concentration gradient.
Are there CRISPR models available for sugar transporter research?
Yes, EDITGENE provides knockout, point mutation, knock-in, and overexpression models for sugar transporter genes, as well as CRISPR library screening and bioinformatics services.
What is the clinical significance of SGLT2 inhibitors?
SGLT2 inhibitors are drugs used to treat type 2 diabetes by blocking renal glucose reabsorption, leading to increased urinary glucose excretion.
How is sugar transporter activity regulated?
Sugar transporter activity is regulated by hormones like insulin, substrate availability, and post-translational modifications; for example, insulin promotes GLUT4 translocation to the plasma membrane.
Conclusion
Sugar transmembrane transporter activity (GO:0051119) is a fundamental molecular function that underpins cellular sugar uptake and metabolism. From facilitative GLUTs to sodium-coupled SGLTs and sugar-phosphate exchangers, these transporters are critical for normal physiology and are implicated in a wide range of diseases, including diabetes, cancer, and neurological disorders. Continued research using advanced CRISPR models and functional assays will further elucidate their mechanisms and therapeutic potential.
References
- 1. Täljedal IB. 1981. On insulin secretion.. Diabetologia 21(1):1-17 PMID: 7024025
- 2. Jack DL et al.. 2001. The drug/metabolite transporter superfamily.. Eur J Biochem 268(13):3620-39 PMID: 11432728
- 3. Oka Y. 1996. [Glucose transporter].. Nihon Rinsho 54(3):632-7 PMID: 8904216
- 4. Wright EM et al.. 1994. 'Active' sugar transport in eukaryotes.. J Exp Biol 196:197-212 PMID: 7823022
- 5. Lipkowitz MS et al.. 2002. Galectin 9 is the sugar-regulated urate transporter/channel UAT.. Glycoconj J 19(7-9):491-8 PMID: 14758072
- 6. Albers M et al.. 2026. Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis.. Nat Commun 17(1) PMID: 41917001
- 7. Chou JY et al.. 2014. The SLC37 family of sugar-phosphate/phosphate exchangers.. Curr Top Membr 73:357-82 PMID: 24745989
- 8. Schmidt S et al.. 2009. GLUT8, the enigmatic intracellular hexose transporter.. Am J Physiol Endocrinol Metab 296(4):E614-8 PMID: 19176349
